Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $3.02M in the quarter ending March 31, 2025, a decrease of -11.79%. This brings the company's revenue in the last twelve months to $14.63M, up 9.47% year-over-year. In the year 2024, Vivos Therapeutics had annual revenue of $15.03M with 8.91% growth.

• Revenue (ttm): $14.63M
• Revenue Growth: +9.47%
• P/S Ratio: 3.04
• Revenue / Employee: $134,202
• Employees: 109
• Market Cap: 37.93M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	15.03M	1.23M	8.91%
Dec 31, 2023	13.80M	-2.22M	-13.87%
Dec 31, 2022	16.02M	-861.00K	-5.10%
Dec 31, 2021	16.89M	3.82M	29.23%
Dec 31, 2020	13.07M	1.67M	14.68%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.